Featured Research

from universities, journals, and other organizations

Asbestos Disease Projections Too Low

Date:
April 4, 2007
Source:
The Australian National University
Summary:
Current predictions of the future incidence of asbestos-related disease have been substantially underestimated, according to new modelling to be presented in Melbourne today by an epidemiologist from the Australian National University.

Current predictions of the future incidence of asbestos-related disease have been substantially underestimated, according to new modelling to be presented in Melbourne today by an epidemiologist from The Australian National University.

The analysis by Dr Mark Clements, from the National Centre for Epidemiology and Population Health, and colleagues shows that the peak number of cases of mesothelioma, a deadly cancer caused by asbestos, will occur four years later and the future total incidence may be in excess of 35 per cent higher than existing models would have predicted. The pattern for mesothelioma reflects changes in asbestos exposure and therefore reflects predictions for all asbestos-related diseases, Dr Clements said.

These early results have important implications for asbestos-related disease liability schemes, Dr Clements said, although more detailed work is needed to properly integrate other factors related to the actuarial implications.

According to the research, an existing model developed by the auditing firm KPMG gave the peak of mesothelioma cases as occurring in 2010, with 3530 cases in New South Wales men. However, Dr Clements said their own epidemiological model showed that the peak could occur as late as 2017 and see 6430 cases of the deadly disease in NSW men.

“There is reasonable evidence that the peak of mesothelioma incidence is later than 2010. This has far reaching consequences for actuarial predictions, where the number of cases out to 2060 may be in excess of 35 per cent higher than the number predicted by KPMG’s model,” he said.

“It is unclear why the two models give different results. The KPMG modeling may have been influenced by a common belief that peak incidence would be in 2010; in contrast, our epidemiological model is able to predict the peak for incidence.

“Although these results have implications for liability, there are several steps between predicting mesothelioma incidence and calculating liability,” he said. “Moreover, modelling would be required for other asbestos-related diseases.

“I can’t speculate as to the revised level of liability. However based on our modelling of future mesothelioma incidence it’s worrying that the liability may have been substantially under-estimated,” Dr Clements said.

Dr Clementspresented this paper at the Accident Compensation Seminar, hosted by the Institute of Actuaries of Australia.


Story Source:

The above story is based on materials provided by The Australian National University. Note: Materials may be edited for content and length.


Cite This Page:

The Australian National University. "Asbestos Disease Projections Too Low." ScienceDaily. ScienceDaily, 4 April 2007. <www.sciencedaily.com/releases/2007/04/070402100931.htm>.
The Australian National University. (2007, April 4). Asbestos Disease Projections Too Low. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/04/070402100931.htm
The Australian National University. "Asbestos Disease Projections Too Low." ScienceDaily. www.sciencedaily.com/releases/2007/04/070402100931.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins